You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復宏漢霖(02696.HK)再斥近8.2億人幣投資上海鬆江生產基地
阿思達克 11-09 17:48
復宏漢霖(02696.HK)公佈,董事會已於近日議決批準對位於上海鬆江區目前在建的復宏漢霖生物醫藥產業化基地(二)之一期項目第三階段投資不超過8.18億元人民幣,用於固定資產投資。 集團指,目前鬆江基地(二)一期項目已完成樁基工程,兩幢主要生產樓已完成結構封頂、主體結構驗收和所有建築部分施工,生產輔助樓的結構封頂以及主體結構驗收工作完成,原液線及製劑線等主要生產設備全面啓動工廠驗收測試。 鬆江基地(二)預計總規劃面積爲200畝,建設完成後,鬆江基地(二)將成爲集團單克隆抗體生物藥研發、中試及生產基地。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account